Minerva Neurosciences, Inc.
Minerva Neurosciences Announces Departure of Directors
WALTHAM, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced the resignation of two members of its board of directors, Michele Ollier and Nico Vandervelpen. Following the Company's recent public offering and the resultant improvement in its financial position, Dr. Ollier and Mr. Vandervelpen will step down to focus on their private equity activities. Their resignations are effective today.
"We would like to thank Michele and Nico for their invaluable contributions to Minerva as a private company and as it has transitioned during the past three years from a venture capital-backed company to a publicly traded company that has advanced several assets into late-stage clinical development," said Marc Beer, chairman of Minerva.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of products to treat CNS diseases. Minerva's proprietary compounds include: MIN-101, in clinical development for schizophrenia; MIN-202 (JNJ-42847922), in clinical development for insomnia and major depressive disorder (MDD); MIN-117, in clinical development for MDD; and MIN-301, in pre-clinical development for Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global Market under the symbol "NERV." For more information, please visit www.minervaneurosciences.com .
William B. Boni
VP, Investor Relations/
Minerva Neurosciences, Inc.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Ascom Holding AG16.1.2018 17:32 | pressemeddelelse
Ascom wins agreement with IDN Munson Healthcare in the USA
Enter16.1.2018 16:42 | pressemeddelelse
Enter Introduces SD-WAN Service on Its National and International Ethernet Infrastructure
Nasdaq16.1.2018 15:03 | pressemeddelelse
Nasdaq Launches passiveIQ(TM) for Investor Relations Professionals
VITEC16.1.2018 15:02 | pressemeddelelse
Canadian Defence Department to Equip its Armored Vehicles With VITEC MGW Diamond TOUGH Encoders
Nasdaq16.1.2018 15:02 | pressemeddelelse
Nasdaq to Deliver Market Technology to Bolsa de Valores de Panamá
TradeStation Group, Inc.16.1.2018 14:02 | pressemeddelelse
TradeStation International Ltd and Interactive Brokers UK Ltd Plan to Offer Global Trading Account
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum